Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2019 - 2025)
Vivos Therapeutics (VVOS) posted quarterly Non-Current Deffered Revenue of $1000.0 for Q3 2025, down 99.44% year-over-year from $178000.0 in Q3 2024, and down 80.0% quarter-over-quarter from $5000.0 in Q2 2025.
Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Non-Current Deffered Revenue for 7 consecutive years, with $1000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Non-Current Deffered Revenue fell 99.44% year-over-year to $1000.0; the TTM figure through Sep 2025 stood at $1000.0 (down 99.44% YoY), while the FY2024 annual figure was $97000.0, down 66.44% from the prior year.
- Non-Current Deffered Revenue slipped to $1000.0 in Q3 2025 per VVOS's latest filing, from $5000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $533000.0 in Q1 2024 and bottomed at $1000.0 in Q3 2025.
- Historically, Non-Current Deffered Revenue has averaged $236235.3 across 5 years, with a median of $250000.0 in 2023.
- Annual changes were most pronounced in 2023 — Non-Current Deffered Revenue surged 158.04% — and 2025, when it tumbled 99.44%.
- Vivos Therapeutics' Non-Current Deffered Revenue stood at $343000.0 in 2021, then plunged by 67.35% to $112000.0 in 2022, then soared by 158.04% to $289000.0 in 2023, then slumped by 66.44% to $97000.0 in 2024, then plunged by 98.97% to $1000.0 in 2025.
- Business Quant data shows VVOS's Non-Current Deffered Revenue at $1000.0 in Q3 2025, $5000.0 in Q2 2025, and $22000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 289,000.00 |
| Sep 30, 2023 | 240,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 180,000.00 |
| Jun 30, 2022 | 317,000.00 |
| Mar 31, 2022 | 375,000.00 |
| Dec 31, 2021 | 343,000.00 |
| Sep 30, 2021 | 360,000.00 |
| Jun 30, 2021 | 358,395.00 |
| Mar 31, 2021 | 212,076.00 |
| Dec 31, 2020 | 146,000.00 |